SIMON SAYS, LET’S TALK BUSINESS: David Dodd with GeoVax copertina

SIMON SAYS, LET’S TALK BUSINESS: David Dodd with GeoVax

SIMON SAYS, LET’S TALK BUSINESS: David Dodd with GeoVax

Ascolta gratuitamente

Vedi i dettagli del titolo

Offerte di stagione | 0,99 €/mese per i primi 3 mesi

A seguire 9,99 €/mese – si applicano condizioni. Puoi disdire mensilmente.
David Dodd/GeoVax GeoVax Labs is a clinical-stage biotechnology company developing novel therapies and vaccines for cancers and many of the world’s most threatening infectious diseases. The company’s lead program in oncology is a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, presently in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax’s […]
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione